Found: 10
Select item for more details and to access through your institution.
Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line.
- Published in:
- Journal of Medical Virology, 2002, v. 68, n. 3, p. 404, doi. 10.1002/jmv.10218
- By:
- Publication type:
- Article
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8<sup>+</sup> T cells in hematogenous metastasis model with lymphocyte infusion.
- Published in:
- Clinical & Experimental Metastasis, 2022, v. 39, n. 2, p. 335, doi. 10.1007/s10585-021-10135-6
- By:
- Publication type:
- Article
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model.
- Published in:
- Clinical & Experimental Metastasis, 2020, v. 37, n. 1, p. 199, doi. 10.1007/s10585-019-10008-z
- By:
- Publication type:
- Article
Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 2, p. 425, doi. 10.3892/ijo.2017.4036
- By:
- Publication type:
- Article
Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93113-y
- By:
- Publication type:
- Article
Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy.
- Published in:
- Cancer Science, 2024, v. 115, n. 1, p. 59, doi. 10.1111/cas.16003
- By:
- Publication type:
- Article
A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients.
- Published in:
- Cancer Science, 2010, v. 101, n. 10, p. 2227, doi. 10.1111/j.1349-7006.2010.01663.x
- By:
- Publication type:
- Article
Anti-VEGF antibody triggers the effect of anti-PD-L1 antibody in PD-L1<sup>low</sup> and immune desert-like mouse tumors.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Sustained effect of continuous treatment with bevacizumab following bevacizumab in combination with chemotherapy in a human ovarian clear cell carcinoma xenograft model.
- Published in:
- Oncology Reports, 2019, v. 42, n. 3, p. 1057, doi. 10.3892/or.2019.7211
- By:
- Publication type:
- Article
Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
- Published in:
- Oncology Reports, 2016, v. 36, n. 2, p. 626, doi. 10.3892/or.2016.4902
- By:
- Publication type:
- Article